© 2005 Oxford University Press
Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
Affiliations of authors: Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (BKE, MLB, LAGR, LH, JW, LWP); Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA (PAW, PMJ, CF); North American Association of Central Cancer Registries, Springfield, IL (HLH); Epidemiology and Surveillance Research Department, American Cancer Society, Atlanta, GA (EW, AJ); Memorial Sloan Kettering Cancer Center, New York, NY (DS); Louisiana State University Health Science Center, Louisiana State University, New Orleans, LA, and North American Association of Central Cancer Registries, Springfield, IL (XCW); Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (RNA)
Correspondence to: Brenda K. Edwards, PhD, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd., Suite 504, Bethesda, MD 20892–8315 (e-mail: edwardsb{at}mail.nih.gov).
Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide information on cancer rates and trends in the United States. This year's report updates statistics on the 15 most common cancers in the five major racial/ethnic populations in the United States for 1992–2002 and features population-based trends in cancer treatment. Methods: The NCI, the CDC, and the NAACCR provided information on cancer cases, and the CDC provided information on cancer deaths. Reported incidence and death rates were age-adjusted to the 2000 U.S. standard population, annual percent change in rates for fixed intervals was estimated by linear regression, and annual percent change in trends was estimated with joinpoint regression analysis. Population-based treatment data were derived from the Surveillance, Epidemiology, and End Results (SEER) Program registries, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Results: Among men, the incidence rates for all cancer sites combined were stable from 1995 through 2002. Among women, the incidence rates increased by 0.3% annually from 1987 through 2002. Death rates in men and women combined decreased by 1.1% annually from 1993 through 2002 for all cancer sites combined and also for many of the 15 most common cancers. Among women, lung cancer death rates increased from 1995 through 2002, but lung cancer incidence rates stabilized from 1998 through 2002. Although results of cancer treatment studies suggest that much of contemporary cancer treatment for selected cancers is consistent with evidence-based guidelines, they also point to geographic, racial, economic, and age-related disparities in cancer treatment. Conclusions: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations. Data from population-based cancer registries, supplemented by linkage with administrative databases, are an important resource for monitoring the quality of cancer treatment. Use of this cancer surveillance system, along with new developments in medical informatics and electronic medical records, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention, detection, and uniformly high quality of care in all areas and populations of the United States.
CiteULike 
Connotea 
Del.icio.us What's this?
Find additional patient-related information at:
This article has been cited by other articles:
|
|
 |
|
  K. Asomaning, A. E. Reid, W. Zhou, R. S. Heist, R. Zhai, L. Su, E. L. Kwak, L. Blaszkowsky, A. X. Zhu, D. P. Ryan, et al. MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis Clin. Cancer Res., June 15, 2008; 14(12): 4010 - 4015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zon, N. J. Meropol, R. B. Catalano, and R. L. Schilsky American Society of Clinical Oncology Statement on Minimum Standards and Exemplary Attributes of Clinical Trial Sites J. Clin. Oncol., May 20, 2008; 26(15): 2562 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahabir, Q. Wei, S. L. Barrera, Y. Q. Dong, C. J. Etzel, M. R. Spitz, and M. R. Forman Dietary magnesium and DNA repair capacity as risk factors for lung cancer Carcinogenesis, May 1, 2008; 29(5): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hemminki, J. Ji, A. Forsti, J. Sundquist, and P. Lenner Concordance of Survival in Family Members With Prostate Cancer J. Clin. Oncol., April 1, 2008; 26(10): 1705 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Hart and R. F. DeMarco Primary Prevention of Skin Cancer in Children and Adolescents: A Review of the Literature Journal of Pediatric Oncology Nursing, April 1, 2008; 25(2): 67 - 78. [Abstract] [PDF]
|
|
|
|
 |
|
 A. M. Lachiewicz, M. Berwick, C. L. Wiggins, and N. E. Thomas Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program Arch Dermatol, April 1, 2008; 144(4): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Z. Stolzenberg-Solomon, K. Adams, M. Leitzmann, C. Schairer, D. S. Michaud, A. Hollenbeck, A. Schatzkin, and D. T. Silverman Adiposity, Physical Activity, and Pancreatic Cancer in the National Institutes of Health-AARP Diet and Health Cohort Am. J. Epidemiol., March 1, 2008; 167(5): 586 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Chaturvedi, E. A. Engels, W. F. Anderson, and M. L. Gillison Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States J. Clin. Oncol., February 1, 2008; 26(4): 612 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Bradley, J. P. Clement, and C. Lin Absence of Cancer Diagnosis and Treatment in Elderly Medicaid-Insured Nursing Home Residents J Natl Cancer Inst, January 2, 2008; 100(1): 21 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Van Dyke, M. L. Cote, G. Prysak, G. B. Claeys, A. S. Wenzlaff, and A. G. Schwartz Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, S. P. Lerner, E. N. Atkinson, H. B. Grossman, N. P. Caraway, C. P. Dinney, D. F. Penson, S. Matin, A. Kamat, L. L. Pisters, et al. Phase III Prevention Trial of Fenretinide in Patients with Resected Non Muscle-Invasive Bladder Cancer Clin. Cancer Res., January 1, 2008; 14(1): 224 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Raghavan, E. A. Perez, and H. A. Harvey Disparities in Cancer Care ASCO Educational Book, January 1, 2008; 2008(1): 270 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Hochster, W. Luo, E. C. Popa, B. T. Lyman, M. Mulcahy, P. A. Beatty, and A. B. Benson Phase II Study of Uracil-Tegafur With Leucovorin in Elderly (>= 75 years old) Patients With Colorectal Cancer: ECOG 1299 J. Clin. Oncol., December 1, 2007; 25(34): 5397 - 5402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Decock, J.-R. Long, R. C. Laxton, X.-O. Shu, C. Hodgkinson, W. Hendrickx, E. G. Pearce, Y.-T. Gao, A. C. Pereira, R. Paridaens, et al. Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis Cancer Res., November 1, 2007; 67(21): 10214 - 10221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Nothlings, S. P. Murphy, L. R. Wilkens, B. E. Henderson, and L. N. Kolonel Flavonols and Pancreatic Cancer Risk: The Multiethnic Cohort Study Am. J. Epidemiol., October 15, 2007; 166(8): 924 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kennedy, A. K. Stewart, K. Y. Bilimoria, L. Patel-Parekh, S. F. Sener, and D. P. Winchester Treatment Trends and Factors Associated with Survival in T1aN0 and T1bN0 Breast Cancer Patients Ann. Surg. Oncol., October 1, 2007; 14(10): 2918 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Leone, L. Pagano, D. Ben-Yehuda, and M. T. Voso Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica, October 1, 2007; 92(10): 1389 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Mutch, M. Orlando, T. Goss, M. G. Teneriello, A. N. Gordon, S. D. McMeekin, Y. Wang, D. R. Scribner Jr, M. Marciniack, R. W. Naumann, et al. Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2811 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Bickell, F. LePar, J. J. Wang, and H. Leventhal Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer Treatment J. Clin. Oncol., June 20, 2007; 25(18): 2516 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bluebond-Langner, J. B. Belasco, A. Goldman, and C. Belasco Understanding Parents' Approaches to Care and Treatment of Children With Cancer When Standard Therapy Has Failed J. Clin. Oncol., June 10, 2007; 25(17): 2414 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kimmelman and J. Nalbantoglu Faithful Companions: A Proposal for Neurooncology Trials in Pet Dogs Cancer Res., May 15, 2007; 67(10): 4541 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Puntoni, S. Zanardi, D. Branchi, S. Bruno, A. Curotto, M. Varaldo, P. Bruzzi, and A. Decensi Prognostic Effect of DNA Aneuploidy from Bladder Washings in Superficial Bladder Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 979 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Katz and S. T. Hawley From Policy To Patients And Back: Surgical Treatment Decision Making For Patients With Breast Cancer Health Aff., May 1, 2007; 26(3): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Howard, M.-T. Ling, C. W. Chua, H. W. Cheung, X. Wang, and Y. C. Wong Garlic-Derived S-allylmercaptocysteine Is a Novel In vivo Antimetastatic Agent for Androgen-Independent Prostate Cancer Clin. Cancer Res., March 15, 2007; 13(6): 1847 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.S. Preventive Services Task Force* Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, March 6, 2007; 146(5): 361 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, M. Lai, H. Yang, J. Lin, M. Huang, H.B. Grossman, C. P. Dinney, and X. Wu Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer Carcinogenesis, March 1, 2007; 28(3): 698 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Levi, F Lucchini, E Negri, and C La Vecchia Continuing declines in cancer mortality in the European Union Ann. Onc., March 1, 2007; 18(3): 593 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Lenburg, A. Sinha, D. V. Faller, and G. V. Denis Tumor-specific and Proliferation-specific Gene Expression Typifies Murine Transgenic B Cell Lymphomagenesis J. Biol. Chem., February 16, 2007; 282(7): 4803 - 4811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Norman, M. A. Adams, K. J. Calfas, J. Covin, J. F. Sallis, J. S. Rossi, C. A. Redding, J. Cella, and K. Patrick A Randomized Trial of a Multicomponent Intervention for Adolescent Sun Protection Behaviors Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 146 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Maturen, H. V. Nghiem, E. M. Caoili, E. G. Higgins, J. S. Wolf Jr., and D. P. Wood Jr. Renal Mass Core Biopsy: Accuracy and Impact on Clinical Management Am. J. Roentgenol., February 1, 2007; 188(2): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Meropol and K. A. Schulman Cost of Cancer Care: Issues and Implications J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Robinson, R. Turrisi, and J. Stapleton Efficacy of a Partner Assistance Intervention Designed to Increase Skin Self-examination Performance Arch Dermatol, January 1, 2007; 143(1): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yao, C.-N. Qian, Z.-F. Zhang, M.-H. Tan, E. J. Kort, X. J. Yang, J. H. Resau, and B. T. Teh Two Distinct Types of Blood Vessels in Clear Cell Renal Cell Carcinoma Have Contrasting Prognostic Implications Clin. Cancer Res., January 1, 2007; 13(1): 161 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hayat, N. Howlader, M. E. Reichman, and B. K. Edwards Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program Oncologist, January 1, 2007; 12(1): 20 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bardia, L. C. Hartmann, C. M. Vachon, R. A. Vierkant, A. H. Wang, J. E. Olson, T. A. Sellers, and J. R. Cerhan Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status Arch Intern Med, December 11, 2006; 166(22): 2478 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sassi, H. S. Luft, and E. Guadagnoli Reducing Racial/Ethnic Disparities in Female Breast Cancer: Screening Rates and Stage at Diagnosis Am J Public Health, December 1, 2006; 96(12): 2165 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Lantz, M. Mujahid, K. Schwartz, N. K. Janz, A. Fagerlin, B. Salem, L. Liu, D. Deapen, and S. J. Katz The Influence of Race, Ethnicity, and Individual Socioeconomic Factors on Breast Cancer Stage at Diagnosis Am J Public Health, December 1, 2006; 96(12): 2173 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blazquez, A. Carracedo, L. Barrado, P. J. Real, J. L. Fernandez-Luna, G. Velasco, M. Malumbres, and M. Guzman Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J, December 1, 2006; 20(14): 2633 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Chen, A. V. D'Amico, B. A. Neville, and C. C. Earle Patient and Treatment Factors Associated With Complications After Prostate Brachytherapy J. Clin. Oncol., November 20, 2006; 24(33): 5298 - 5304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-R. Chien and M.-S. Lai Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center. American Journal of Medical Quality, November 1, 2006; 21(6): 408 - 414. [Abstract] [PDF]
|
|
|
|
 |
|
 H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, J. B. McKinlay, and for the Boston Area Community Health Survey Invest Serum Androgen Levels in Black, Hispanic, and White Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4326 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Singh and L. Johnson Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin. Cancer Res., September 15, 2006; 12(18): 5312 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Barlow, E. White, R. Ballard-Barbash, P. M. Vacek, L. Titus-Ernstoff, P. A. Carney, J. A. Tice, D. S. M. Buist, B. M. Geller, R. Rosenberg, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst, September 6, 2006; 98(17): 1204 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M WARD, M. J THUN, L. M HANNAN, and A. JEMAL Interpreting cancer trends. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 29 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Chan, M. K. Cheung, A. Husain, N. N. Teng, D. West, A. S. Whittemore, J. S. Berek, and K. Osann Patterns and Progress in Ovarian Cancer Over 14 Years. Obstet. Gynecol., September 1, 2006; 108(3): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Press, J. M. Unger, R. M. Braziel, D. G. Maloney, T. P. Miller, M. LeBlanc, and R. I. Fisher Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911 J. Clin. Oncol., September 1, 2006; 24(25): 4143 - 4149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cross and J. K. Burmester Gene therapy for cancer treatment: past, present and future. Clin. Med. Res., September 1, 2006; 4(3): 218 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Calcabrini, J. M. Garcia-Martinez, L. Gonzalez, M. J. Tendero, M. T. A. Ortuno, P. Crateri, A. Lopez-Rivas, G. Arancia, P. Gonzalez-Porque, and J. Martin-Perez Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate Carcinogenesis, August 1, 2006; 27(8): 1699 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Caffarel, D. Sarrio, J. Palacios, M. Guzman, and C. Sanchez {Delta}9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation. Cancer Res., July 1, 2006; 66(13): 6615 - 6621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzman, G. Velasco, and J. L. Iovanna Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress-Related Genes. Cancer Res., July 1, 2006; 66(13): 6748 - 6755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Varmus The new era in cancer research. Science, May 26, 2006; 312(5777): 1162 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jones, J. A. Chilton, R. A. Hajek, N. K. Iammarino, and L. Laufman Between and Within: International Perspectives on Cancer and Health Disparities J. Clin. Oncol., May 10, 2006; 24(14): 2204 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Grann and F. M. Muggia Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective. J Natl Cancer Inst, May 3, 2006; 98(9): 570 - 571. [Full Text] [PDF]
|
|
|
|
|
|
C. C. Gotay Increasing Trial Generalizability J. Clin. Oncol., February 20, 2006; 24(6): 846 - 847. [Full Text] [PDF] |